WZB117BAY-876ipilimumab2-deoxy-D-glucoseNSCLCnon-small cell lung cancers
… mutational burden in predicting benefit. In KEAP1-mutant PDXs, WZB117 restored sensitivity to anti-PD-1 therapy, validating translati…
1articles mentioning drugs
2drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: WZB117 ×
WZB117
This drug is selected. Its supporting articles are shown below.